Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|10|1103-1114

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.10, 2003-01, pp. : 1103-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesyl transferase inhibitors in clinical development

By Caponigro Francesco   Casale Marina   Bryce Jane  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 943-954

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl Protein Transferase Inhibitor ZARNESTRA™ R115777 - History of a Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1095-1102

Bentham Science Publishers

Access to resources Recommend Favorite

Heteronemin as a Protein Farnesyl Transferase Inhibitor

By Ledroit Véronique   Debitus Cécile   Ausseil Frédéric   Raux Roselyne   Menou Jean-Louis   Hill Bridget  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 6, 2004-09 ,pp. : 454-456

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl transferase inhibitors in the treatment of breast cancer

By Kelland Lloyd R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 413-421

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl Transferase Inhibitors as Potential Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 19, 2018-11 ,pp. : 1611-1623

Bentham Science Publishers

Access to resources Recommend Favorite